Douglas C. Wolf, MD, FACG

Atlanta Gastroenterology Associates LLC

Poster(s):

• C0387 - Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Moderate or Severe Endoscopic Disease Activity at Baseline: A Post Hoc Analysis of the Phase 3 True North Study
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET